A citation-based method for searching scientific literature

Ionut Bebu, Barbara H Braffett, Rodica Pop-Busui, Trevor J Orchard, David M Nathan, John M Lachin. Diabetologia 2017
Times Cited: 37







List of co-cited articles
461 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Jeanine B Albu, Jiang Lu, Arshag D Mooradian, Ronald J Krone, Richard W Nesto, Marty H Porter, Jamal S Rana, William J Rogers, Burton E Sobel, Sheldon H Gottlieb. Obesity (Silver Spring) 2010
19
5

Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
Arpeeta Sharma, Judy S Y Choi, Nada Stefanovic, Annas Al-Sharea, Daniel S Simpson, Nigora Mukhamedova, Karin Jandeleit-Dahm, Andrew J Murphy, Dmitri Sviridov, James E Vince,[...]. Diabetes 2021
8
12

Hemostasis, endothelial stress, inflammation, and the metabolic syndrome.
Gerald Grandl, Christian Wolfrum. Semin Immunopathol 2018
81
2

Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.
Cecilia Morgantini, Andrea Natali, Beatrice Boldrini, Satoshi Imaizumi, Mohamad Navab, Alan M Fogelman, Ele Ferrannini, Srinivasa T Reddy. Diabetes 2011
115
2


Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials.
Marit de Jong, H Bart van der Worp, Yolanda van der Graaf, Frank L J Visseren, Jan Westerink. Cardiovasc Diabetol 2017
49
2


Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
Aruna D Pradhan, Nina P Paynter, Brendan M Everett, Robert J Glynn, Pierre Amarenco, Marshall Elam, Henry Ginsberg, William R Hiatt, Shun Ishibashi, Wolfgang Koenig,[...]. Am Heart J 2018
135
2



Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Rena R Wing, Paula Bolin, Frederick L Brancati, George A Bray, Jeanne M Clark, Mace Coday, Richard S Crow, Jeffrey M Curtis, Caitlin M Egan, Mark A Espeland,[...]. N Engl J Med 2013
2

Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association.
Linda Van Horn, Jo Ann S Carson, Lawrence J Appel, Lora E Burke, Christina Economos, Wahida Karmally, Kristie Lancaster, Alice H Lichtenstein, Rachel K Johnson, Randal J Thomas,[...]. Circulation 2016
172
2


Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Srinivasan Beddhu, Glenn M Chertow, Tom Greene, Paul K Whelton, Walter T Ambrosius, Alfred K Cheung, Jeffrey Cutler, Lawrence Fine, Robert Boucher, Guo Wei,[...]. J Am Heart Assoc 2018
34
2

Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials.
Nerea Becerra-Tomás, Sonia Blanco Mejía, Effie Viguiliouk, Tauseef Khan, Cyril W C Kendall, Hana Kahleova, Dario Rahelić, John L Sievenpiper, Jordi Salas-Salvadó. Crit Rev Food Sci Nutr 2020
48
2


Inflammation, adiposity, and progression of arterial stiffness in adolescents with type 1 diabetes: The SEARCH CVD Study.
Amy C Alman, Jennifer W Talton, R Paul Wadwa, Elaine M Urbina, Lawrence M Dolan, Richard F Hamman, Ralph B D'Agostino, Santica M Marcovina, Dana M Dabelea. J Diabetes Complications 2018
7
14

Recipes for creating animal models of diabetic cardiovascular disease.
Willa Hsueh, E Dale Abel, Jan L Breslow, Nobuyo Maeda, Richard C Davis, Edward A Fisher, Hayes Dansky, Donald A McClain, Richard McIndoe, Momtaz K Wassef,[...]. Circ Res 2007
164
2

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie Baccara-Dinet, Deepak L Bhatt, Vera A Bittner, Andrzej J Budaj, Rafael Diaz, Shaun G Goodman, Corinne Hanotin,[...]. Lancet Diabetes Endocrinol 2019
90
2

Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk.
Henry L Elliott, Suzanne M Lloyd, Ian Ford, Peter A Meredith. Int J Hypertens 2011
8
12

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
2


NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction.
Prabhakara R Nagareddy, Gopalkrishna Sreejit, Mohamed Abo-Aly, Robert M Jaggers, Lakshman Chelvarajan, Jillian Johnson, Gerard Pernes, Baskaran Athmanathan, Ahmed Abdel-Latif, Andrew J Murphy. Arterioscler Thromb Vasc Biol 2020
5
20

Postprandial VLDL-TG metabolism in type 2 diabetes.
Esben Søndergaard, Rakel Fuglsang Johansen, Michael D Jensen, Søren Nielsen. Metabolism 2017
11
9

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Giuseppe Mancia, Morris Brown, Alain Castaigne, Peter de Leeuw, Christopher R Palmer, Talma Rosenthal, Gilbert Wagener, Luis M Ruilope. Hypertension 2003
116
2


Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
Lars Sjöström, Markku Peltonen, Peter Jacobson, Sofie Ahlin, Johanna Andersson-Assarsson, Åsa Anveden, Claude Bouchard, Björn Carlsson, Kristjan Karason, Hans Lönroth,[...]. JAMA 2014
539
2

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.
Ali Aminian, Alexander Zajichek, David E Arterburn, Kathy E Wolski, Stacy A Brethauer, Philip R Schauer, Michael W Kattan, Steven E Nissen. JAMA 2019
110
2



Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
559
2

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Walter N Kernan, Catherine M Viscoli, Karen L Furie, Lawrence H Young, Silvio E Inzucchi, Mark Gorman, Peter D Guarino, Anne M Lovejoy, Peter N Peduzzi, Robin Conwit,[...]. N Engl J Med 2016
537
2


Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Alan S Go, Glenn M Chertow, Dongjie Fan, Charles E McCulloch, Chi-yuan Hsu. N Engl J Med 2004
2

Cardiovascular morbidity and mortality associated with the metabolic syndrome.
B Isomaa, P Almgren, T Tuomi, B Forsén, K Lahti, M Nissén, M R Taskinen, L Groop. Diabetes Care 2001
2

Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Brian A Ference, John J P Kastelein, Kausik K Ray, Henry N Ginsberg, M John Chapman, Chris J Packard, Ulrich Laufs, Clare Oliver-Williams, Angela M Wood, Adam S Butterworth,[...]. JAMA 2019
211
2

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
Richard J Stevens, Ruth L Coleman, Amanda I Adler, Irene M Stratton, David R Matthews, Rury R Holman. Diabetes Care 2004
179
2


The sex differential in mortality from all causes and ischemic heart disease.
D L Wingard, L Suarez, E Barrett-Connor. Am J Epidemiol 1983
193
2


Sex differences in coronary mortality among diabetics in Evans County, Georgia.
S Heyden, G Heiss, A G Bartel, C G Hames. J Chronic Dis 1980
127
2

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis, L G Hunsicker, W R Clarke, T Berl, M A Pohl, J B Lewis, E Ritz, R C Atkins, R Rohde, I Raz. N Engl J Med 2001
2


Glycemic control in patients with diabetes in Finland.
T Valle, V A Koivisto, A Reunanen, T Kangas, A Rissanen. Diabetes Care 1999
42
2


Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.
Petter Bjornstad, Michal Schäfer, Uyen Truong, Melanie Cree-Green, Laura Pyle, Amy Baumgartner, Yesenia Garcia Reyes, Aristides Maniatis, Sunil Nayak, R Paul Wadwa,[...]. Circulation 2018
52
2

Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes.
Jingchuan Guo, Maria M Brooks, Matthew F Muldoon, Ashely I Naimi, Trevor J Orchard, Tina Costacou. Diabetes Care 2019
4
25

Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes.
Harold S Starkman, Gregory Cable, Virginia Hala, Harvey Hecht, Christine M Donnelly. Diabetes Care 2003
37
2


Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.
Rachel G Miller, Trevor J Orchard, Tina Costacou. Diabetes Res Clin Pract 2020
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.